Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice

Journal of Surgical Research

Volumn 178, Issue 1, 2012, Pages 460-465

  Hu, Honglin ^a   Zou, Cong ^a   Xi, Xiaoqing ^a   Shi, Ziming ^a   Wang, Gongxian ^a   Huang, Xueming ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Apoptosis; Ischemia reperfusion injury; Kidney; Pioglitazone

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY CELL; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; REPERFUSION INJURY; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; CREATININE; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; KIDNEY TUBULES; MALE; MICE; MICE, INBRED BALB C; RANDOM ALLOCATION; REPERFUSION INJURY; THIAZOLIDINEDIONES;

EID: 84868203406     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.01.012     Document Type: Article

References (23)

1. Z. Aydin, A.J. van Zonneveld, and J.W. de Fijter New horizons in prevention and treatment of ischaemic injury to kidney transplants Nephrol Dial Transplant 22 2007 342
2. H. Hu, C. Chéreau, and C. Gobeaux Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischemia-reperfusion injury J Pathol 225 2011 265
3. P.T. Vianna, Y.M. Castiglia, and J.R. Braz Remifentanil, isoflurane, and preconditioning attenuate renal ischemia/reperfusion injury in rats Transplant Proc 41 2009 4080
4. M.G. Pereira, N.O. Câmara, and G. Campaholle Pioglitazone limits cyclosporine nephrotoxicity in rats Int Immunopharmacol 6 2006 1943
5. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function Curr Opin Lipidol 14 2003 459
6. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu Rev Med 53 2002 409
7. N. Papanas, N. Katsiki, and A.I. Hatzitolios Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus Expert Opin Pharmacother 12 2011 1457
8. W.A. Hsueh, and M.J. Quiñones Role of endothelial dysfunction in insulin resistance Am J Cardiol 92 2003 10J
9. G. Haraguchi, H. Kosuge, and Y. Maejima Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis Intensive Care Med 34 2008 1304
10. T. Shimazu, I. Inoue, and N. Araki A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia Stroke 36 2005 353
11. L.A. Ahmed, H.A. Salem, and A.S. Attia Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats Eur J Pharmacol 663 2011 51
12. B. Medhi, R. Aggarwal, and A. Chakrabarti Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice Indian J Exp Biol 48 2010 793
13. H. Hu, G. Wang, and F. Batteux Gender differences in the susceptibility to renal ischemia-reperfusion injury in BALB/c mice Tohoku J Exp Med 218 2009 325
14. H. Rabb, C.C. Mendiola, and J. Dietz Role of CD11a and CD11b in ischemic acute renal failure in rats Am J Physiol 267 1994 F1052
15. K. Schoonjans, and J. Auwerx Thiazolidinediones: An update Lancet 355 2000 1008
16. R.B. Goldberg, D.M. Kendall, and M.A. Deeg A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia Diabetes Care 28 2005 1547
17. T. Honda, K. Kaikita, and K. Tsujita Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders J Mol Cell Cardiol 44 2008 915
18. J. Li, M.J. Lang, and X.B. Mao Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat Cardiovasc Drugs Ther 22 2008 283
19. Q. Wei, G. Dong, and J. Franklin The pathological role of Bax in cisplatin nephrotoxicity Kidney Int 72 2007 53
20. Q. Wei, X.M. Yin, and M.H. Wang Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice Am J Physiol Renal Physiol 290 2006 F35
21. K.J. Kelly, T.A. Sutton, and N. Weathered Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury Am J Physiol Renal Physiol 287 2004 F760
22. H.T. Lee, G. Gallos, and S.H. Nasr A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice J Am Soc Nephrol 15 2004 102
23. E.J. Sharples, N. Patel, and P. Brown Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion J Am Soc Nephrol 15 2004 2115